NIH, U.S. agencies pay for nearly half of global health R&D

Uncle Sam has been a champion of backing research of global health concerns that plague populations well outside of U.S. borders, according to a study by Global Health Technologies. In fact, U.S. agencies led by the National Institutes of Health have footed 45% of the bill covering research of diseases such as HIV and other scourges to global health, spending $12.7 billion over the past decade. Yet much of that funding went into basic research, and the study calls for greater focus on backing work to translate findings into treatments. Article

Suggested Articles

Fifteen of the 22 patients in a gene therapy trial no longer needed transfusions, while the remainder needed fewer transfusions.

Argos Therapeutics is ending its kidney cancer trial and mulling options, including a merger or sale, to stay alive.

CNS Pharma says berubicin is the first anthracycline drug to cross the blood-brain barrier and could transform treatment of the highly invasive brain tumor.